Skip to main content
Premium Trial:

Request an Annual Quote

Ezose, Fast Forward Team on MS Biomarker Research

NEW YORK (GenomeWeb News) – Ezose Sciences today said that it will collaborate with Fast Forward, a subsidiary of the National Multiple Sclerosis Society, to discover biomarkers that may help diagnose multiple sclerosis, improve disease management, and help guide development of new MS medicines.

Under the alliance, Ezose will collaborate with Anthony Reder, a professor of neurology at the University of Chicago. Researchers will use Ezose's GlycanMap to discover new biomarkers associated with MS. The GlycanMap platform combines high-throughput glycan enrichment with specialized MALDI-TOF mass spectrometry and bioinformatics to identify and quantitate glycans in complex biological samples.

Pine Brook, NJ-based Ezose said that it will receive up to $390,000 from Fast Forward to support the studies. Further terms were not disclosed.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.